SARS-CoV-2 vaccine development: is a finish line in sight?

This exclusive, extended webinar covers the latest developments in the journey towards COVID-19 vaccines – for both Australia and the world.

View the video of this webinar to:

• gain an understanding of the current COVID-19 vaccine development landscape, clinical trials and next steps in vaccine deployment
• learn about the Coalition for Epidemic Preparedness Innovation (CEPI)’s COVAX response to COVID-19 from Dr Melanie Saville
• hear about where we are now in Australia and internationally and realistic expectations for the next 6–12 months 
• consider the ethical and logistical implications of global vaccine implementation, specifically approaches for the Indo-Pacific region  

Speakers: 

Dr Melanie Saville, Director of Vaccine Research & Development, Coalition for Epidemic Preparedness Innovations (CEPI)

Melanie Saville joined CEPI in November 2017 initially as Head of Clinical development and is now Director, Vaccine Research and Development. Melanie is a physician specialised in virology with more than 18 years’ experience in the development and licensure of vaccines for the developed and developing world. Over the years, she has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, pediatric combinations, rabies, Japanese encephalitis and dengue in Europe, the United States of America and internationally.

Associate Professor Christopher Blyth, Co-Director, Wesfarmers Centre of Vaccines and Infectious Diseases, Paediatric Infectious Diseases Physician and Clinical Microbiologist

Dr Chris Blyth is a clinical academic and NHMRC Emerging Leadership Fellow. He is Associate Professor of Paediatrics, University of Western Australia and Co-director of Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute. He leads the Department of Paediatric Infectious Diseases at Perth Children's Hospital. The majority of his research is in influenza, vaccine-preventable respiratory tract infection, pneumonia and vaccine safety. 

Discussion panel (speakers joined by):

Professor Paul Kelly, Acting Chief Medical Officer, Australian Government Department of Health

Dr Stephanie Williams, Australian Ambassador for Regional Health Security, Department of Foreign Affairs and Trade (DFAT)

Professor Kristine Macartney, Director, NCIRS

Last updated November 2020